Nexgel (NXGL) Current Deferred Revenue (2020 - 2025)

Nexgel (NXGL) posted Current Deferred Revenue of $2000.0 for Q4 2025, down 98.89% on a QoQ basis from $180000.0 in Q3 2025, and down 98.88% year-over-year from $179000.0 in Q4 2024.

Nexgel (NXGL) Current Deferred Revenue (2020 - 2025) Analysis & Trends

Nexgel's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $2000.0 for Q4 2025.

  • Quarterly Current Deferred Revenue fell 98.88% year-over-year to $2000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2000.0 (down 98.88% YoY) and the FY2025 annual result came in at $2000.0, down 98.88% from the prior year.
  • Current Deferred Revenue was $2000.0 for Q4 2025 at Nexgel, down from $180000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $286000.0 in Q1 2025 and bottomed at $2000.0 in Q4 2025.
  • A 4-year average of $138818.2 and a median of $179000.0 in 2024 frame the typical range for Current Deferred Revenue.
  • Annual changes were most pronounced in 2024 — Current Deferred Revenue surged 795.0% — and 2025, when it plunged 98.88%.
  • Nexgel's Current Deferred Revenue stood at $38000.0 in 2021, then plunged by 47.37% to $20000.0 in 2023, then surged by 795.0% to $179000.0 in 2024, then plunged by 98.88% to $2000.0 in 2025.
  • Business Quant data shows NXGL's Current Deferred Revenue at $2000.0 in Q4 2025, $180000.0 in Q3 2025, and $180000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Nexgel 3.50 Mn 2.13 Mn 819,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 2,000.00
Sep 30, 2025 180,000.00
Jun 30, 2025 180,000.00
Mar 31, 2025 286,000.00
Dec 31, 2024 179,000.00
Sep 30, 2024 179,000.00
Jun 30, 2024 179,000.00
Mar 31, 2024 250,000.00
Dec 31, 2023 20,000.00
Sep 30, 2023 34,000.00
Mar 31, 2021 38,000.00
Dec 31, 2020 38,000.00